Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solar-Stage
NCT06235151Phase 3Active, not recruiting
- Sponsor
- Curium
- Start
- Apr 2024
- Primary completion
- Oct 2026
- Modality
- Radiopharmaceutical, CA (Contrast Agent)
- Countries
- 1
01
Overview
A Phase 3 trial of copper Cu 64 PSMA I&T in prostate cancer (PCa), sponsored by Curium. Started Apr 2024; status: active, not recruiting.
02
Drugs
copper Cu 64 PSMA I&T
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06235151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06235151.